The announcement of Addex Therapeutics' partnership with Perceptive Advisors to launch Neurosterix is a significant development for the company. Partnerships with reputable firms like Perceptive Advisors can provide both financial support and strategic advantages, leading to positive investor sentiment and a potential increase in stock price. The immediate positive reaction in the stock market reflects the high relevance and importance of this news to Addex Therapeutics and its investors.